228 related articles for article (PubMed ID: 24352457)
21. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.
McLellan JS; Yang Y; Graham BS; Kwong PD
J Virol; 2011 Aug; 85(15):7788-96. PubMed ID: 21613394
[TBL] [Abstract][Full Text] [Related]
22. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
Seyfizadeh N; Kalbermatter D; Imhof T; Ries M; Müller C; Jenner L; Blumenschein E; Yendrzheyevskiy A; Grün F; Moog K; Eckert D; Engel R; Diebolder P; Chami M; Krauss J; Schaller T; Arndt M
J Biomed Sci; 2024 May; 31(1):56. PubMed ID: 38807208
[TBL] [Abstract][Full Text] [Related]
23. Structure-Based Mutations in the Herpes Simplex Virus 1 Glycoprotein B Ectodomain Arm Impart a Slow-Entry Phenotype.
Fan Q; Kopp SJ; Connolly SA; Longnecker R
mBio; 2017 May; 8(3):. PubMed ID: 28512095
[TBL] [Abstract][Full Text] [Related]
24. Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526.
Kong L; Kadam RU; Giang E; Ruwona TB; Nieusma T; Culhane JC; Stanfield RL; Dawson PE; Wilson IA; Law M
J Mol Biol; 2015 Aug; 427(16):2617-28. PubMed ID: 26135247
[TBL] [Abstract][Full Text] [Related]
25. Structural basis of respiratory syncytial virus neutralization by motavizumab.
McLellan JS; Chen M; Kim A; Yang Y; Graham BS; Kwong PD
Nat Struct Mol Biol; 2010 Feb; 17(2):248-50. PubMed ID: 20098425
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.
McLellan JS
Curr Opin Virol; 2015 Apr; 11():70-5. PubMed ID: 25819327
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.
Jin J; Liss NM; Chen DH; Liao M; Fox JM; Shimak RM; Fong RH; Chafets D; Bakkour S; Keating S; Fomin ME; Muench MO; Sherman MB; Doranz BJ; Diamond MS; Simmons G
Cell Rep; 2015 Dec; 13(11):2553-2564. PubMed ID: 26686638
[TBL] [Abstract][Full Text] [Related]
28. Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies.
Vance DJ; Poon AY; Mantis NJ
PLoS One; 2020; 15(11):e0236538. PubMed ID: 33166282
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity.
Earnest JT; Basore K; Roy V; Bailey AL; Wang D; Alter G; Fremont DH; Diamond MS
J Exp Med; 2019 Oct; 216(10):2282-2301. PubMed ID: 31337735
[TBL] [Abstract][Full Text] [Related]
30. A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization.
Lochridge VP; Hardy ME
J Virol; 2007 Nov; 81(22):12316-22. PubMed ID: 17804495
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization.
May JS; Stevenson PG
J Gen Virol; 2010 Oct; 91(Pt 10):2542-52. PubMed ID: 20519454
[TBL] [Abstract][Full Text] [Related]
32. Conformational Change in Herpes Simplex Virus Entry Glycoproteins Detected by Dot Blot.
Sari TK; Gianopulos KA; Nicola AV
Methods Mol Biol; 2020; 2060():319-326. PubMed ID: 31617187
[TBL] [Abstract][Full Text] [Related]
33. Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.
Bootz A; Karbach A; Spindler J; Kropff B; Reuter N; Sticht H; Winkler TH; Britt WJ; Mach M
PLoS Pathog; 2017 Aug; 13(8):e1006601. PubMed ID: 28854233
[TBL] [Abstract][Full Text] [Related]
34. Conformational Changes in Herpes Simplex Virus Glycoprotein C.
Gianopulos KA; Komala Sari T; Weed DJ; Pritchard SM; Nicola AV
J Virol; 2022 Aug; 96(16):e0016322. PubMed ID: 35913218
[TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.
Powell LA; Fox JM; Kose N; Kim AS; Majedi M; Bombardi R; Carnahan RH; Slaughter JC; Morrison TE; Diamond MS; Crowe JE
PLoS Pathog; 2020 May; 16(5):e1008517. PubMed ID: 32365139
[TBL] [Abstract][Full Text] [Related]
36. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity.
Long F; Fong RH; Austin SK; Chen Z; Klose T; Fokine A; Liu Y; Porta J; Sapparapu G; Akahata W; Doranz BJ; Crowe JE; Diamond MS; Rossmann MG
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13898-903. PubMed ID: 26504196
[TBL] [Abstract][Full Text] [Related]
37. Glycoprotein B switches conformation during murid herpesvirus 4 entry.
Gillet L; Colaco S; Stevenson PG
J Gen Virol; 2008 Jun; 89(Pt 6):1352-1363. PubMed ID: 18474550
[TBL] [Abstract][Full Text] [Related]
38. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.
Magro M; Andreu D; Gómez-Puertas P; Melero JA; Palomo C
J Virol; 2010 Aug; 84(16):7970-82. PubMed ID: 20534864
[TBL] [Abstract][Full Text] [Related]
39. Virus neutralization assays for human respiratory syncytial virus using airway organoids.
van Dijk LLA; Rijsbergen LC; Rubio BT; Schmitz KS; Gommers L; Comvalius AD; Havelaar A; van Amerongen G; Schepp R; Lamers MM; GeurtsvanKessel CH; Haagmans BL; van Binnendijk R; de Swart RL; de Vries RD
Cell Mol Life Sci; 2024 Jun; 81(1):267. PubMed ID: 38884678
[TBL] [Abstract][Full Text] [Related]
40. Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies.
Nagata S; Okamoto Y; Inoue T; Ueno Y; Kurata T; Chiba J
Arch Virol; 1992; 127(1-4):153-68. PubMed ID: 1280941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
